Precigen Corp (PGEN) - Uzoq muddatli qarzning kapitalga koeffitsiyenti
Precigen, Inc. (PGEN) uchun joriy narxlar grafigi UltraVector tizimi orqali gen terapiyasini ishlab chiqayotgan biznesning ko'rsatkichi bo'lib xizmat qiladi, bunda muvaffaqiyat PRGN-2012 ning FDA tomonidan tasdiqlanishiga va xarajatlar nazoratiga bog'liq. Kompaniya hozirda kam uchraydigan respirator patologiyalar uchun davolash vositalarini tijoriy ravishda ishga tushirish bosqichiga o'tmoqda va ushbu ko'rsatkich 2.39 darajasida turibdi. O'sish modeli mualliflik huquqiga ega dori vositalarining yuqori marjasi dastlabki R&D xarajatlarini qoplashiga asoslanadi.
%20Uzoq%20muddatli%20qarzning%20kapitalga%20nisbati&width=1200&height=400&colorIndex=0&v=mvujvhid.si-7ayy9s0&start=20220704&end=20261030&filename=GURU_Markets_-_PGEN_-_Precigen-Inc._-_Long-Term-Debt-to-Capital "PGEN: Precigen Uzoq muddatli qarzning kapitalga nisbati 04.07.2022 - 30.10.2026 | 👁️GURU.Markets👁️")
Precigen, Inc. (PGEN) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Precigen, Inc.|PGEN - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati precigen.com|PGEN - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Precigen, Inc.|PGEN - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz hajmi Precigen|Tezkor likvidlik ko‘rsatkichi precigen.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
Kompaniyaning umumiy tahlili:Precigen Inc - PGEN
Ushbu ko'rsatkich kompaniyaning uzoq muddatli majburiyatlarning kapitalga nisbatan bog'liqligini baholaydi, bu esa qarz olish xarajatlari tebransa, haddan tashqari yuqori kredit yuklamasi xatarlarini aniqlash imkonini beradi. 2.39 ning joriy qiymati va uzoq muddatli qarzlarning kapitalga nisbatidagi tendentsiyasi Precigen, Inc. moliyaviy barqarorligini aks ettiradi, uning ishlab chiqarish va sinovlarni tashqi hamkorlarga autsorsing qilish strategiyasi kapital xarajatlarini minimallashtiradi, natijada ulkan qarz moliyalashtirishga bo'lgan ehtiyojni kamaytiradi.
Muhim raqobatchilar
argenx N.V. - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati BNTX|ABVX (Abivax S.A.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ADMA (ADMA Biologics)|Uzoq muddatli qarzning kapitalga nisbati protagonist-inc.com PTGX|IMVT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti KNSA (Kiniksa Pharmaceuticals, Ltd.)|Grifols Group (GRFS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Adaptive Biotechnologies Inc.|CLDX (Celldex Therapeutics) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati auriniapharma.com|Uzoq muddatli qarzning o'z kapitaliga nisbati BCRX (BioCryst Pharmaceuticals)|VERA (Vera Therapeutics Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati DNTH (Dianthus Pharma)|Uzoq muddatli qarzdorlikning kapitalga nisbati Pharvaris Pharma (PHVS)|ABCL - Uzoq muddatli qarzning o'z kapitaliga nisbati|tourmalinebio.com (TRML) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Pharming Group (PHAR) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Nektar Therapeutics Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati UPB|Uzoq muddatli qarzning kapitalga nisbati Zenas Corp|Uzoq muddatli qarzning o'z kapitaliga nisbati Immunome, Inc. (IMNM)|gossamerbio.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Uzoq muddatli majburiyatlarning kapitalga nisbati|PVLA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati SVRA|Rigel Pharmaceuticals (RIGL) - Uzoq muddatli qarzning o'z kapitaliga nisbati|anaptysbio.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|ATXS (Astria Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati enGene Holdings Inc ENGN|Uzoq muddatli qarzning kapitalga nisbati RAPT|Uzoq muddatli qarzning o'z kapitaliga nisbati aerovatetx.com JBIO|Uzoq muddatli qarzning kapitalga nisbati ACRS (Aclaris Therapeutics)|Uzoq muddatli qarzdorlikning kapitalga nisbati kyvernatx.com (KYTX)|Tiziana Life Sciences Ltd - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Cabaletta Bio Inc. (CABA)|VTYX: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Theratechnologies, Inc (THTX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Avalo Therapeutics, Inc|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ELDN (eledon.com)|Uzoq muddatli qarzning o'z kapitaliga nisbati AGEN (Agenus Inc.)|CLYM (Climb Bio Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ZURA (Zura Bio Limited)|Uzoq muddatli qarzdorlikning kapitalga nisbati aTyr Pharmaceuticals (ATYR)|ADAG - Uzoq muddatli qarzning o'z kapitaliga nisbati|IMA (ImageneBio Inc) - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|STTK: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Equillium|Uzoq muddatli qarzning o'z kapitaliga nisbati CNTB|Immunic Inc (IMUX) - Uzoq muddatli qarzdorlikning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Atara Biotherapeutics (ATRA)|IFRX: Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati XFOR (X4 Pharmaceuticals, Inc.)|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati Adicet Bio Inc.|Celularity Corp - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati INmune Bio Corporation|Barinthus Biotherapeutics (BRNS) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi KZR|Uzoq muddatli qarzning o'z kapitaliga nisbati SAB Biotherapeutics, Inc.|Akari Therapeutics PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ENLV|QTTB (q32bio.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GOVX (GeoVax Labs, Inc.)|Uzoq muddatli qarzning kapitalga nisbati edesabiotech.com EDSA|IBIO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti CARM (Carisma Therapeutics)|XTL Biopharmaceuticals, Ltd. (XTLB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Bolt Biotherapeutics, Inc.|HCWB (HCW Biologics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Aptevo|Uzoq muddatli qarzning o'z kapitaliga nisbati AIM (AIM ImmunoTech)|ADTX (aditxt.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati GRI (GRI Bio Corp)|Uzoq muddatli qarzdorlikning kapitalga nisbati XORTX Corp (XRTX)|HIND - Uzoq muddatli qarzning o'z kapitaliga nisbati|revbiosciences.com (REVB) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Indaptus Therapeutics, Inc. (INDP) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Scinai Immunotherapeutics Ltd|Uzoq muddatli qarzning o'z kapitaliga nisbati CALI|Uzoq muddatli qarzning kapitalga nisbati Affimed Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati Allakos Inc. (ALLK)|hookipapharma.com - Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Uzoq muddatli qarzning kapitalga nisbati IGMS (IGM Biosciences)|iTeos Therapeutics Inc (ITOS) - Uzoq muddatli majburiyatlarning kapitalga nisbati|OCEA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati TCBP|Third Harmonic Bio (THRD) - Uzoq muddatli qarzning o'z kapitaliga nisbati